.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The JANANI digital health platform marks a structural reform in India's maternal and child health administration. This innovative system streamlines digital health records for women during their reproductive years. Moreover, it ensures that every beneficiary receives seamless care across the continuum. The Union Health Ministry launched this upgraded version of the RCH portal to improve service accountability.
The Ministry introduced QR-enabled digital Mother and Child Health (MCH) cards to enhance portability. These cards allow patients to access their medical history across any healthcare facility. Furthermore, the platform integrates seamlessly with national systems like U-WIN and POSHAN. Consequently, healthcare providers can now identify high-risk pregnancies through automated alerts. Similarly, these targeted interventions significantly improve clinical outcomes for mothers and newborns.
The JANANI digital health platform enables real-time monitoring via comprehensive dashboards for supervisory reviews. Frontline health workers benefit from automated due-list generation for tracking beneficiaries. Additionally, the pan-India search functionality supports continuity of care for migratory populations. Providers can register and verify users using ABHA, Aadhaar, or biometric authentication. Therefore, the system effectively prevents record duplication while maintaining longitudinal health histories. Doctors will find that this platform simplifies administration and improves long-term health outcomes.
Q1: What is the JANANI digital health platform?
JANANI is a service-oriented digital platform from the Union Health Ministry designed to track maternal and child health records comprehensively from pregnancy through childhood.
Q2: How does the platform handle high-risk pregnancies?
The platform incorporates automated alerts for high-risk pregnancies, which allows healthcare providers to implement timely and targeted clinical interventions.
Q3: How do beneficiaries register for this platform?
Beneficiaries can register using unique identifiers like ABHA or Aadhaar through OTP, biometric authentication, or their mobile numbers.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
India's Health Ministry launched JANANI, a digital platform for real-time tracking of maternal and child health services through QR-enabled MCH records....
5 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
